What is BioCircuit Technologies?
BioCircuit Technologies specializes in the development and commercialization of advanced medical devices focused on tissue repair and neuromodulation. Their flagship product, Nerve Tape®, is the first FDA-cleared sutureless device designed for repairing transected nerves, enhancing surgical efficiency and reducing tissue damage. The company aims to empower clinicians with innovative tools that improve the diagnosis and treatment of nerve injuries across various medical specialties. BioCircuit Technologies serves healthcare professionals, particularly in plastic and reconstructive surgery, by providing solutions that streamline nerve repair procedures.
How much funding has BioCircuit Technologies raised?
BioCircuit Technologies has raised a total of $9M across 1 funding round:
Angel/Seed
$9M
Angel/Seed (2022): $9M with participation from GRA Venture Fund and Masters Capital Management
Key Investors in BioCircuit Technologies
GRA Venture Fund
GRA Venture Fund is a public-private venture capital fund that invests in research-driven startup companies based in Georgia, focusing on elite enterprises that have emerged from science and technology.
Masters Capital Management
Masters Capital Management, LLC is an Atlanta-based SEC registered investment adviser specializing in managing a single investment strategy focused on US equities and listed equity options, aiming to deliver long-term outsized absolute returns.
What's next for BioCircuit Technologies?
The recent major strategic investment positions BioCircuit Technologies for accelerated growth and market penetration. This capital infusion is expected to fuel further research and development, expand manufacturing capabilities, and enhance commercialization efforts for their innovative nerve repair solutions. The company's focus on addressing critical needs in surgical procedures suggests a trajectory towards becoming a leader in the medical device industry, with potential for further strategic partnerships and market expansion.
See full BioCircuit Technologies company page
